We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
UK, US and Canada regret Russia's lack of response to the Vienna Mechanism of March 2024 on prison conditions and call for immediate humanitarian release of Vladimir Kara-Murza.
UK and 40 other OSCE States regret Russia's lack of response to Vienna Mechanism of March 2024 on prison conditions in Russia.
Businessman applied for two Bounce Back Loans and failed to disclose existence of first loan to liquidators
Gerard Lemos joined the HMPPS as Lead Non-Executive Board Member on 1 May 2018. Gerard is Chair of English Heritage, London Institute of Banking and Finance and Hofesh Shechter Dance Company. He is the author of many publications about social...
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Check the tariff classification for oilcake and other residues resulting from the extraction of olive oil.
Decision for applicant British Broadcasting Corporation against registration number 14988089, applicant successful.
Ffurflen i'w llenwi gan ymarferwyr meddygol cofrestredig i ryddhau corff i'w amlosgi.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Information on variants of the SARS-CoV-2 virus.
Use this form to record decisions for the recovery of the environment following a radiation incident.
Product Safety Report for H Cosmetiques CI L'abidjanaise Cream presenting a serious chemical risk.
This is a list of all the opinions the RPC issued in 2023 on Foreign, Commonwealth and Development Office measures
This is a list of all the opinions the RPC issued in 2023 on Financial Conduct Authority measures.
Volume 39 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.